ClinicalTrials.gg
Drug

Montelukast clinical trials

Also written Singulair and MK0476.

studies test it
227
open now
16
in phase 3
70
first study started
1995

How each study uses montelukast is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the montelukast studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Feb 1998 · SINGULAIR · NDA 020829 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Montelukast
118
montelukast sodium
48
Comparator: Montelukast
7
Montelukast 10mg
7
Montelukast 10 Mg Oral Tablet
4

Brand

Singulair
75

Development codes

MK0476
13

In one entry with another drug

Given together, or one or the other

Comparator: montelukast/loratadine
2

Studies by the year they started

225 studies that test it; most in 2007 (22)

Studies that test montelukast, by start year
YearStudies
19951
19971
19992
20004
20017
20023
200310
20048
200517
200618
200722
200810
20094
201018
201112
201210
20139
20146
20154
20163
20173
20185
20198
20206
20218
20226
20237
20242
20254
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
9
Phase 1
30
Phase 2
39
Phase 3
70
Phase 4
69
No phase
24

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 80 · Other 147

Organon and Co (46) · GlaxoSmithKline (5) · Dr. Reddy's Laboratories Limited (5) · Roxane Laboratories (4) · Medical University of Lodz (4) · University of Colorado, Denver (4) · Assiut University (3) · Hanmi Pharmaceutical Company Limited (3)

Often tested with

Tested in the same studies.

Fluticasone (9) · Salmeterol Xinafoate (7) · Budesonide (6) · Loratadine (5) · Levocetirizine (4) · Azithromycin (3) · Prednisone (3) · Flurbiprofen (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7, 2 in phase 3

Studies that test montelukast, phase 3 first.

Studies

Open first, then newest update. How each study uses montelukast is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 227

See all 227 studies that test montelukast →

Given beside what is tested · 27 — montelukast is usual care or a partner of the new treatment

Showing 20 of 27.

As the comparator · 20 — what is tested is compared with montelukast

Codes

What other systems call montelukast · ClinicalTrials.gg INT003850

  • MeSH (NLM) C093875montelukastConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) MHM278SD3EMONTELUKASTConfirmed FDA, NLM, Wikidata
  • RxNorm 88249Confirmed FDA, Wikidata
  • Wikidata Q417767montelukastConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66189MontelukastOne source FDA
  • DrugBank DB00471One source Wikidata

Also registered as montelukast sodium (UNII U1O3J18SFL · RxNorm 115713).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.